ストックスクリーナーアプリを入手
1.06
1.92%
0.02
アフターアワーズ：
1.10
0.04
+3.77%
Icecure Medical Ltd (ICCM) 最新ニュース
ICCMIcecure Medical Ltd | News - OTC Markets
A director will serve until November 2 as IceCure Medical (ICCM) removes his re-election agenda items. - Stock Titan
Part of IceCure Medical (ICCM)'s proposed chairman grant depends on at least $6.5 million in financing. - Stock Titan
ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally? - Stocktwits
IceCure Secures China NMPA Approval for ProSense Cryoablation System - Yahoo Finance
ICCM Looks 89.8% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
Icecure Medical Receives Regulatory Approval to Market Prosense in China - marketscreener.com
IceCure Medical (ICCM) secures China nod for tumor-freezing cancer tool - Stock Titan
China approves a tumor-freezing system from IceCure - Stock Titan
IceCure Medical Ltd. (ICCM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Icecure Medical Earnings Call Signals Early Growth Phase - TipRanks
IceCure and Scovas agree for ProSense distribution in Netherlands - Yahoo Finance
IceCure (ICCM) Results at a Glance: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Post-Earnings: Shares Move 6.58% Down in Latest TradingTax Rate Impact - vinanet.vn
Icecure Medical Ltd. Signs Exclusive Distribution Agreement with Scovas Medical for Prosense Cryoablation Systems in the Netherlands - marketscreener.com
IceCure (ICCM) Results at a Glance: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Post-Earnings: Shares Move 6.58% Down in Latest TradingTangible Book Value - careplusvn.com
IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands - PR Newswire
IceCure (ICCM) Results at a Glance: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Post-Earnings: Shares Move 6.58% Down in Latest TradingEarnings Seasonality - dars.gov.et
IceCure (ICCM) Results at a Glance: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Post-Earnings: Shares Move 6.58% Down in Latest TradingEarnings Season Outlook - dars.gov.et
IceCure (ICCM) Earnings Report: Profit Per Share Falls Below Its Benchmark for the Current Session; Market Response - vinanet.vn
IceCure (ICCM) Earnings Report: Profit Per Share Falls Below Its Benchmark for the Current Session; Market Response - careplusvn.com
IceCure (ICCM) Earnings Report: Profit Per Share Falls Below Its Benchmark for the Current Session; Market Response: The Share Price Sheds 0.82% in the Latest ReadingSubscription Growth Report - www.dars.gov.et
IceCure Medical (ICCM): Commercial Adoption Is Improving, but the Reimbursement and Scale Story Still Needs More Proof - AlphaStreet
ICCM Looks 87.8% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
IceCure says West Cancer Center IRB clears ChoICE breast cancer cryoablation study - Bitget
IceCure's ProSense Is First and Only for Low-Risk Breast Cancer With FDA Marketing Authorization - Stock Titan
West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation - PR Newswire
Icecure Medical Ltd (ICCM) (Q2 2026) Earnings Call Highlights: R - GuruFocus
IceCure Medical (ICCM) Q2 2026 Earnings Call Transcript - AOL.ca
IceCure (ICCM) Earnings Report: EPS Misses Its Estimate under the Current Snapshot; Share Response - vinanet.vn
IceCure Medical Ltd. SEC Filing (Aug 19, 2026) - Stock Titan
IceCure (ICCM) Earnings Report: EPS Misses Its Estimate under the Current Snapshot; Share Response - careplusvn.com
IceCure (ICCM) Earnings Report: EPS Misses Its Estimate under the Current Snapshot; Share Response - www.dars.gov.et
IceCure (ICCM) Earnings Report: EPS Misses Its Estimate under the Current Snapshot; Share Response - dars.gov.et
IceCure Medical (ICCM) grants 131K RSUs to North America VP - Stock Titan
IceCure Medical : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
IceCure Medical (NASDAQ: ICCM) director lists no shares - Stock Titan
IceCure (NASDAQ: ICCM) VP now holds 106K shares and RSUs - Stock Titan
IceCure Medical (ICCM) awards COO 141K new RSUs - Stock Titan
IceCure Medical (NASDAQ: ICCM) adds 73,890 RSUs to VP HR stake - Stock Titan
IceCure Medical (ICCM) director Chan Vincent leaves board - Stock Titan
ICCM Looks 85.8% Undervalued on GF Value™ - GuruFocus
IceCure Medical (NASDAQ: ICCM) awards CFO 181K stock units at $0 - Stock Titan
IceCure Medical director David Salton files initial beneficial ownership statement - Bitget
IceCure Medical (ICCM) expands 2024 employee share incentive reserve - Stock Titan
Armistice Capital (ICCM) reports 300,332 IceCure Medical shares under shared control - Stock Titan
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
IceCure Medical (ICCM) Earnings Call zum 2. Quartal 2026: Umsatz im 1. Halbjahr steigt um 45 % - TradingKey
IceCure Medical (ICCM) details 324,802-share warrant issuance and $9.7M potential proceeds - Stock Titan
New studies highlight FDA-approved ProSense cry... - pluang.com
Two papers examine tumor freezing beyond the primary breast tumor - Stock Titan
18.66%
4.17%
大文字化:
|
ボリューム (24 時間):